Show items per page
Elements: 7
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Novel histone deacetylase 6 (HDAC6) selective inhibitors: a patent evaluation (WO2014181137) Simoes Avello, Claudia; Bertrand, Philippe; Cuendet Licea, Muriel 2017
add to browser selection
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma Cosset, Erika; Ilmjarv, Sten; Dutoit Vallotton, Valérie; Elliott, Kathryn; ... Cheresh, David A 2017
add to browser selection
Cellular and molecular effects of the mTOR inhibitor everolimus Saran, Uttara; Foti, Michelangelo; Dufour, Jean-François 2015
add to browser selection
Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets? Ruiz Altaba, Ariel 2008
add to browser selection
17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30 Vivacqua, Adele; Bonofiglio, Daniela; Albanito, Lidia; Madeo, Antonio; ... Maggiolini, Marcello 2006
add to browser selection
Transcription regulator LMO4 interferes with neuritogenesis in human SH-SY5Y neuroblastoma cells Vu, Dung; Marin, Pascale; Walzer, Claude; Cathieni, Maria Margherita; ... Savioz, Armand 2003
add to browser selection
Adriamycin impairs phagocytic function and induces morphologic alterations in human neutrophils Vaudaux, Pierre; Kiefer, B.; Forni, Michel; Joris, I.; ... Waldvogel, Francis 1984